Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions
Abstract Synthetic biology has allowed for the industrial production of supply-limited sesquiterpenoids such as the antimalarial drug artemisinin and β-farnesene. One of the only unmodified animal products used in medicine is squalene, a triterpenoid derived from shark liver oil, which when formulat...
Main Authors: | Karl J. Fisher, Robert Kinsey, Raodoh Mohamath, Tony Phan, Hong Liang, Mark T. Orr, William R. Lykins, Jeffrey A. Guderian, Julie Bakken, David Argilla, Gabi Ramer-Denisoff, Elise Larson, Yizhi Qi, Sandra Sivananthan, Karina Smolyar, Darrick Carter, Christopher J. Paddon, Christopher B. Fox |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-023-00608-y |
Similar Items
-
Screening of Oligomeric (Meth)acrylate Vaccine Adjuvants Synthesized via Catalytic Chain Transfer Polymerization
by: Cordula S. Hege, et al.
Published: (2023-09-01) -
From Sharks to Yeasts: Squalene in the Development of Vaccine Adjuvants
by: Adélia Mendes, et al.
Published: (2022-02-01) -
Squalene Emulsions for Parenteral Vaccine and Drug Delivery
by: Christopher B. Fox
Published: (2009-09-01) -
Author Correction: A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
by: Emily A. Voigt, et al.
Published: (2022-11-01) -
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
by: Emily A. Voigt, et al.
Published: (2022-11-01)